Targeted Protein Degradation through Recruitment of the CUL4 Complex Adaptor Protein DDB1
ACS Chemical Biology · 2024
DOI: 10.1021/acschembio.3c00487 ↗At a glance
Journal article in ACS Chemical Biology, 2024. Written by Margot Meyers and 4 co-authors. Institution: Department of Chemistry, University of California, Berkeley, Berkeley, California 94720, United States. Major MEDLINE topics: Cullin Proteins, Transcription Factors. Cited 41 times so far (Crossref); 36 references. The full text is freely available in PubMed Central. Funded by: NCI NIH HHS, NIH HHS, Division of Chemistry.
Abstract (original language)
Targeted protein degradation has arisen as a powerful therapeutic modality for eliminating proteins. Thus far, most heterobifunctional proteolysis targeting chimeras (PROTACs) have utilized recruiters against substrate receptors of Cullin RING E3 ubiquitin ligases, such as cereblon and VHL. However, previous studies have surprisingly uncovered molecular glue degraders that exploit a CUL4 adaptor protein DDB1 to degrade neosubstrate proteins. Here, we sought to investigate whether DDB1 recruiters can be discovered that can be exploited for PROTAC applications. We utilized activity-based protein profiling and cysteine chemoproteomic screening to identify a covalent recruiter that targets C173 on DDB1 and exploited this recruiter to develop PROTACs against BRD4 and androgen receptor (AR). We demonstrated that the BRD4 PROTAC results in selective degradation of the short BRD4 isoform over the long isoform in a proteasome, NEDDylation, and DDB1-dependent manner. We also demonstrated degradation of AR with the AR PROTAC in prostate cancer cells. Our study demonstrated that covalent chemoproteomic approaches can be used to discover recruiters against Cullin RING adapter proteins and that these recruiters can be used for PROTAC applications to degrade neo-substrates.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Chemistry, University of California, Berkeley, Berkeley, California 94720, United States.
- Novartis-Berkeley Translational Chemical Biology Institute, Berkeley, California 94720, United States.
- Innovative Genomics Institute, Berkeley, California 94720, United States.
- Novartis Institutes for BioMedical Research, Emeryville, California 94608, United States.
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, United States.
ORCID profiles: Daniel K Nomura
Funding
- NCI NIH HHS
- NIH HHS
- Division of Chemistry
- Novartis Institutes for BioMedical Research
- National Cancer Institute
- Mark Foundation For Cancer Research
- Novartis-Berkeley Translational Chemical Biology Institute
- Nomura Research Group, University of California Berkeley
Cite
APA
Meyers, M., Cismoski, S., Panidapu, A., Chie-Leon, B., & Nomura, D. K. (2024). Targeted Protein Degradation through Recruitment of the CUL4 Complex Adaptor Protein DDB1. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00487
Vancouver
Meyers M, Cismoski S, Panidapu A, Chie-Leon B, Nomura DK. Targeted Protein Degradation through Recruitment of the CUL4 Complex Adaptor Protein DDB1. ACS Chemical Biology. 2024. doi:10.1021/acschembio.3c00487
BibTeX
@article{Meyers2024,
author = {Meyers, Margot and Cismoski, Sabine and Panidapu, Anoohya and Chie-Leon, Barbara and Nomura, Daniel K},
title = {Targeted Protein Degradation through Recruitment of the CUL4 Complex Adaptor Protein DDB1},
journal = {ACS Chemical Biology},
year = {2024},
doi = {10.1021/acschembio.3c00487}
}
EUVIMED